Immunicum AB (publ) Provides Additional Information on the Proposed Transaction and Virtual Investor Event Summary

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Immunicum AB (publ) Provides Additional Information on the Proposed Transaction and Virtual Investor Event Summary
 7:30:00 PM

Keep reading
Immunicum AB (publ) Receives FDA Fast Track Designation for Ilixadencel in Gastrointestinal Stromal Tumors (GIST)Read